From Name:
From Email:
To Name:
To Email:

Optional Message:

First dedicated coronary bifurcation stent receives FDA approval

from Healio

Tryton Medical Inc. announced the FDA premarket approval of a stent designed for the treatment of coronary bifurcation lesions involving large side branches. The stent is the first specifically designed for treatment of coronary bifurcation lesions to receive FDA approval, according to a press release issued by the company. According to the release, PCI of bifurcation lesions has typically been performed with provisional stenting of the main branch, but in many cases, the side branch is left unstented, which may make the side branch vulnerable to complications, such as occlusion that requires bailout stenting. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063